Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

31.20

+0.04 (0.13%)

At close: Dec 5, 2025, 4:00 PM EST

30.69

-0.51 (-1.63%)

After-hours: Dec 5, 2025, 7:56 PM EST

Arcutis Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '25 Dec 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Market Capitalization	3,822	1,630	305	901	1,043	1,225	Upgrade
Market Cap Growth	223.61%	434.82%	-66.18%	-13.58%	-14.88%	-	Upgrade
Enterprise Value	3,744	1,508	283	626	681	1,039	Upgrade
Last Close Price	31.20	13.93	3.23	14.80	20.74	28.13	Upgrade
PS Ratio	12.40	8.30	5.11	244.56	-	-	Upgrade
PB Ratio	23.74	10.35	3.44	4.30	3.50	4.53	Upgrade
P/TBV Ratio	26.78	11.01	3.71	4.45	3.50	4.53	Upgrade
EV/Sales Ratio	11.78	7.67	4.75	169.88	-	-	Upgrade
Debt / Equity Ratio	0.72	0.70	2.32	0.97	0.26	0.02	Upgrade
Asset Turnover	0.79	0.57	0.15	0.01	-	-	Upgrade
Inventory Turnover	1.75	1.38	0.48	-	-	-	Upgrade
Quick Ratio	3.07	3.72	6.38	11.06	11.61	12.61	Upgrade
Current Ratio	3.50	4.14	7.08	11.57	12.09	12.96	Upgrade
Return on Equity (ROE)	-28.17%	-113.76%	-175.79%	-122.80%	-72.62%	-72.93%	Upgrade
Return on Assets (ROA)	-5.91%	-23.25%	-38.12%	-43.97%	-36.55%	-42.14%	Upgrade
Return on Capital (ROIC)	-7.51%	-28.52%	-42.64%	-47.89%	-39.67%	-45.26%	Upgrade
Return on Capital Employed (ROCE)	-14.10%	-47.90%	-81.80%	-73.30%	-55.10%	-49.60%	Upgrade
Earnings Yield	-1.16%	-8.59%	-85.99%	-34.55%	-19.78%	-11.07%	Upgrade
FCF Yield	-0.87%	-6.89%	-81.18%	-28.63%	-16.84%	-9.25%	Upgrade
Buyback Yield / Dilution	-11.93%	-74.53%	-25.94%	-11.39%	-38.52%	-1835.11%	Upgrade

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q